RT Journal Article
SR Electronic
T1 When Second Best Might be the Best: Using Hospitalization Data to Monitor the Novel Coronavirus Pandemic
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.11.20098475
DO 10.1101/2020.05.11.20098475
A1 Mallow, Peter J.
A1 Jones, Michael
YR 2020
UL http://medrxiv.org/content/early/2020/05/18/2020.05.11.20098475.abstract
AB The novel coronavirus’ high rate of asymptomatic transmission combined with a lack of testing kits call for a different approach to monitor its spread and severity. We proposed the use of hospitalizations and hospital utilization data to monitor the spread and severity. A proposed threshold of a declining 7-day moving average over a 14-day period, “7&14” was set to communicate when a wave of the novel coronavirus may have passed. The state of Ohio was chosen to illustrate this threshold. While not the ideal solution for monitoring the spread of the epidemic, the proposed approach is an easy to implement framework accounting for limitations of the data inherent in the current epidemic. Hospital administrators and policy makers may benefit from incorporating this approach into their decision making.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe authors did not receive any funding for this research nor have any conflicts of interest regarding this research to report.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe authors will make all data available upon reasonable request.